Total Voting Rights

GlaxoSmithKline PLC
01 April 2008



                        Total Voting Rights and Capital


In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc
("the Company") hereby notifies the market of the following:

The Company's issued share capital as at 31 March 2008 consisted of
5,904,232,208 Ordinary shares of 25p each with voting rights, of which 
484,194,158 Ordinary shares are held in Treasury.

Therefore, the total number of voting rights in the Company is 5,420,038,050.
This figure may be used by shareholders as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in, the Company under the Financial Services
Authority's Disclosure and Transparency Rules.


S M Bicknell
Company Secretary

1 April 2008




                      This information is provided by RNS
            The company news service from the London Stock Exchange